302 related articles for article (PubMed ID: 18183858)
1. Part XV. Antiretroviral therapy for human immunodeficiency virus infection.
Stephens JR; Rathbun RC; Lockhart SM; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2007 Nov; 100(11):417-24. PubMed ID: 18183858
[TBL] [Abstract][Full Text] [Related]
2. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
3. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Pinheiro Edos S; Antunes OA; Fortunak JM
Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
[TBL] [Abstract][Full Text] [Related]
4. Current status and challenges of antiretroviral research and therapy.
Esté JA; Cihlar T
Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
[TBL] [Abstract][Full Text] [Related]
5. Advances in HIV/AIDS therapy.
Johnson SC; Gerber JG
Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
[TBL] [Abstract][Full Text] [Related]
6. [Salvage therapy for HIV infection].
Salzberger B
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():32-7. PubMed ID: 16385870
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
[TBL] [Abstract][Full Text] [Related]
8. Mutation and control of the human immunodeficiency virus.
Stengel RF
Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy 2010 update: current practices and controversies.
Grant M; Samuel R; Bettiker RL; Suh B
Arch Pharm Res; 2011 Jul; 34(7):1045-53. PubMed ID: 21811910
[TBL] [Abstract][Full Text] [Related]
10. Potential of polymeric nanoparticles in AIDS treatment and prevention.
Khalil NM; Carraro E; Cótica LF; Mainardes RM
Expert Opin Drug Deliv; 2011 Jan; 8(1):95-112. PubMed ID: 21143001
[TBL] [Abstract][Full Text] [Related]
11. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
Wilson LE; Gallant JE
Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
[TBL] [Abstract][Full Text] [Related]
12. Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting.
Sherer R
Semin Oncol; 1998 Apr; 25(2 Suppl 6):92-7. PubMed ID: 9625390
[TBL] [Abstract][Full Text] [Related]
13. An overview of the human immunodeficiency virus featuring laboratory testing for drug resistance.
Scosyrev E
Clin Lab Sci; 2006; 19(4):231-45; quiz 246-9. PubMed ID: 17181129
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy.
Wood E; Montaner JS; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
J Infect Dis; 2003 Oct; 188(8):1164-70. PubMed ID: 14551887
[TBL] [Abstract][Full Text] [Related]
15. Therapy of HIV infection.
Chang YC; Tyring SK
Dermatol Ther; 2004; 17(6):449-64. PubMed ID: 15571495
[TBL] [Abstract][Full Text] [Related]
16. Current management of AIDS and related opportunistic infections.
Cochran A; Wilson BA
Medsurg Nurs; 1999 Aug; 8(4):257-64. PubMed ID: 10661162
[TBL] [Abstract][Full Text] [Related]
17. [AIDS treatment in Africa: the risk of antiretroviral resistance].
Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
[TBL] [Abstract][Full Text] [Related]
18. Current clinical treatments of AIDS.
Murphy EM; Jimenez HR; Smith SM
Adv Pharmacol; 2008; 56():27-73. PubMed ID: 18086408
[No Abstract] [Full Text] [Related]
19. The impacts of current antiretroviral therapy regimens on Chinese AIDS patients and their implications for HIV-1 drug resistance mutation.
Zhang M; Han XX; Cui WG; Jia MH; Meng XD; Xing AH; Wu YH; Yang YY; Lu CM; Hu QH; Dai D; Zhang ZN; Shang H
Jpn J Infect Dis; 2008 Sep; 61(5):361-5. PubMed ID: 18806342
[TBL] [Abstract][Full Text] [Related]
20. [Hypersensitivity syndrome--the role of pharmacogenetics for prediction of efficacy and safety of antiretroviral therapy in patients with HIV/AIDS].
Cholewińska G
Przegl Epidemiol; 2008; 62(1):149-54. PubMed ID: 18536238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
